Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
retatrutide clinical trials retatrutide weight loss for Loss: 2026 Research Reference Size:36 Servings We have dosed the Longevity
We have dosed the first participants in VESPER-6, the latest Phase 3 trial of our lead investigational medicine in obesity. It is the next of around 20 pivotal studies we are starting
Cost containment is key as companies consider benefits redesign and alternative health plan models
Longevity
Size:36 Servings
Unfortunately, as mentioned earlier, weight regain is common after discontinuation
